Research location

Glyfada

Greece

Published trials7
Site observations8
Linked trials published7
Page1 / 1
Advertisement

Research activity in Glyfada

Greece

CureCurrent currently publishes aggregate city-level research activity for this location: 7 trials and 8 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Glyfada

7 linked trials · page 1 of 1
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderNCT04041284 · 2019-09-13 · 1 site observation
COMPLETED
COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal GelNCT03362879 · 2017-12-14 · 1 site observation
COMPLETED
A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)NCT02799381 · 2017-02-09 · 1 site observation
COMPLETED
A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)NCT02549092 · 2015-10-26 · 1 site observation
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 1 site observation
TERMINATED
A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With EprosartanNCT01562613 · 2012-03-01 · 2 site observations
COMPLETED
Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)NCT02389933 · 1 site observation
NO_LONGER_AVAILABLE

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.